2025 annual financial data

Keros Therapeutics 2025 Net margin

Direct answer

Net margin was 35.65%.

Operating income was 70.62M USD and net income was 87.01M USD.
Operating cash flow was 107.51M USD.

Get free Keros Therapeutics email updates.

Bullstory sends one daily email when new analysis or important company news is available.

Verified data

Revenue
244.06M USD
Operating income
70.62M USD
Net income
87.01M USD
Operating cash flow
107.51M USD